Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,016 | 563 | 97.4% |
| Education | $266.84 | 10 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,495 | 122 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $834.12 | 45 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $758.02 | 31 | $0 (2023) |
| Amgen Inc. | $743.16 | 47 | $0 (2024) |
| Allergan, Inc. | $654.76 | 46 | $0 (2020) |
| Lilly USA, LLC | $532.53 | 30 | $0 (2024) |
| GlaxoSmithKline, LLC. | $532.18 | 25 | $0 (2024) |
| Radius Health, Inc. | $514.41 | 21 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $440.82 | 25 | $0 (2024) |
| PFIZER INC. | $403.19 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $779.47 | 42 | Amgen Inc. ($134.29) |
| 2023 | $904.14 | 52 | Novo Nordisk Inc ($136.30) |
| 2022 | $1,095 | 65 | Novo Nordisk Inc ($216.00) |
| 2021 | $1,712 | 109 | Novo Nordisk Inc ($389.52) |
| 2020 | $1,699 | 103 | Novo Nordisk Inc ($302.70) |
| 2019 | $811.07 | 56 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($211.96) |
| 2018 | $2,057 | 82 | Medtronic Vascular, Inc. ($294.70) |
| 2017 | $1,226 | 64 | SANOFI-AVENTIS U.S. LLC ($354.72) |
All Payment Transactions
573 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Diabetes Care | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Inflammation | ||||||
| 10/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $4.15 | General |
| Category: Cardiology | ||||||
| 09/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Diabetes Care | ||||||
| 09/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $3.79 | General |
| Category: Inflammation | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $4.39 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $110.10 | General |
| 07/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Inflammation | ||||||
| 07/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Diabetes | ||||||
| 06/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Diabetes Care | ||||||
| 05/30/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Diabetes | ||||||
| 05/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Cardio-renal | ||||||
| 04/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Inflammation | ||||||
| 04/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Diabetes Care | ||||||
| 04/22/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 3,845 | 13,289 | $608,852 | $284,215 |
| 2022 | 32 | 3,915 | 11,579 | $586,317 | $264,276 |
| 2021 | 35 | 4,784 | 12,291 | $671,017 | $295,778 |
| 2020 | 38 | 4,667 | 17,382 | $706,627 | $263,937 |
All Medicare Procedures & Services
141 procedure records from CMS Medicare Utilization — Page 2 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 15 | 15 | $4,525 | $1,314 | 29.0% |
| 98925 | Osteopathic manipulative treatment, 1-2 body regions | Office | 2023 | 28 | 36 | $2,020 | $849.80 | 42.1% |
| 97035 | Application of ultrasound, each 15 minutes | Office | 2023 | 46 | 91 | $2,275 | $789.45 | 34.7% |
| 97012 | Application of mechanical traction | Office | 2023 | 46 | 91 | $3,185 | $714.31 | 22.4% |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | Office | 2023 | 46 | 90 | $2,700 | $562.09 | 20.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 11 | 22 | $660.00 | $356.84 | 54.1% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 16 | 19 | $800.00 | $222.02 | 27.8% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 18 | 41 | $1,260 | $167.15 | 13.3% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 47 | 222 | $3,360 | $88.18 | 2.6% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 54 | 85 | $2,125 | $63.56 | 3.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 17 | 76 | $1,520 | $29.32 | 1.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 351 | 926 | $124,975 | $87,970 | 70.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 250 | 294 | $57,330 | $38,842 | 67.8% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 212 | 237 | $47,265 | $15,024 | 31.8% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 114 | 124 | $37,200 | $12,067 | 32.4% |
| 86003 | Measurement of antibody (ige) to allergic substance, crude allergen extract, each | Office | 2022 | 73 | 2,220 | $22,200 | $11,404 | 51.4% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 80 | 3,240 | $32,400 | $10,624 | 32.8% |
| 82306 | Vitamin d-3 level | Office | 2022 | 249 | 339 | $22,035 | $9,924 | 45.0% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2022 | 114 | 124 | $43,400 | $8,251 | 19.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 86 | 112 | $10,640 | $7,364 | 69.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 247 | 410 | $18,450 | $6,812 | 36.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 51 | 52 | $14,300 | $5,889 | 41.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 80 | 126 | $10,710 | $5,086 | 47.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $7,460 | $4,832 | 64.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 278 | 494 | $14,820 | $4,731 | 31.9% |
About Dr. Ross Nochimson, M.D
Dr. Ross Nochimson, M.D is a Internal Medicine healthcare provider based in Lauderhill, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1023157500.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ross Nochimson, M.D has received a total of $10,283 in payments from pharmaceutical and medical device companies, with $779.47 received in 2024. These payments were reported across 573 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($10,016).
As a Medicare-enrolled provider, Nochimson has provided services to 17,211 Medicare beneficiaries, totaling 54,541 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 141 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Lauderhill, FL
- Active Since 02/05/2007
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1023157500
Products in Payments
- Ozempic (Drug) $950.11
- FARXIGA (Drug) $552.63
- Tymlos (Biological) $500.63
- TRELEGY ELLIPTA (Drug) $483.63
- XIFAXAN (Drug) $430.21
- Vascepa (Drug) $378.12
- JARDIANCE (Drug) $362.31
- Otezla (Drug) $354.40
- SOLIQUA (Drug) $335.22
- TRULICITY (Drug) $273.73
- SOLIQUA 100/33 (Biological) $243.29
- Kerendia (Drug) $239.78
- XARELTO (Drug) $232.73
- AirSeal (Device) $209.82
- BYSTOLIC (Drug) $209.50
- FREESTYLE LIBRE 2 (Device) $191.57
- Micra (Device) $182.65
- UBRELVY (Drug) $177.30
- FREESTYLE LIBRE 3 (Device) $155.10
- VRAYLAR (Drug) $143.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lauderhill
Dr. Sean Nochimson, D.o, D.O
Internal Medicine — Payments: $3,872
Dr. Jessica Geller, M.d, M.D
Internal Medicine — Payments: $990.36
Herbert Slavin, Md, MD
Internal Medicine — Payments: $717.60
Dr. Daniel Leon Roumain, M.d, M.D
Internal Medicine — Payments: $610.80
Dr. John Wolf, M.d, M.D
Internal Medicine — Payments: $189.45
Natasha Cedeno, M.d, M.D
Internal Medicine — Payments: $47.29